Imaging AI firm Brainomix plans to launch its next-generation stroke AI platform, Brainomix 360, at the upcoming International Stroke Conference in New Orleans.
The new platform and feature upgrade offer a net water uptake capability using routine noncontrast CT scans.
"The automated net water uptake output complements Brainomix's unique ischemic core volume, and e-ASPECTS features to provide clinicians across all hospital settings with deeper insights into stroke injury using a routine noncontrast CT scan," said the company's chief medical and innovation officer, George Harston, MD, in a statement. "Emerging evidence is increasingly highlighting net water uptake as a vital imaging biomarker to inform treatment decisions and improve prognostication in the most severe strokes."
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
